These findings suggested that the serum periostin levels in patients with OSA may reflect a combination of its downregulation by obesity and upregulation by hypoxic stimulation or metabolic comorbidities. This evidence concerns the gene POSTN and obesity due to melanocortin 4 receptor deficiency.